LEADER 01089nam2-2200361---450 
001 990006106100203316
005 20190204130047.0
010   $a978-3-319-20824-4
035   $a000610610
035   $aUSA01000610610
035   $a(ALEPH)000610610USA01
035   $a000610610
100   $a20110331d2015----km-y0itay50------ba
101   $aeng
102   $aDE
105   $aa---||||001yy
200 1 $aEndocannabinoids$fRoger G.
210   $aCham [etc.]$aHeidelberg$cSpringer$dcopyr. 2015
215   $aXII, 475 p.$cill.$d24 cm
225 2 $aHandbook of experimental pharmacology$v231
410  0$1001000320432$12001$aHandbook of experimental pharmacology$v, 231
606 0 $aCanapa indiana$xUso terapeutico$2BNCF
676   $a615.7827
702  1$aPERTWEE,$bRoger G.
801  0$aIT$bsalbc$gISBD
912   $a990006106100203316
951   $a615.782 END 1$b5906 Farm.$c615$d00331109
959   $aBK
969   $aFAR
979   $aPAOLA$b90$c20151215$lUSA01$h1228
979   $aPAOLA$b90$c20151215$lUSA01$h1234
996   $aEndocannabinoids$91383799
997   $aUNISA